Trials / Sponsors / Acerand Therapeutics (Hong Kong) Limited
Acerand Therapeutics (Hong Kong) Limited
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer) | Phase 1 | 2025-05-12 |